Metraipolis › archive › dc_552a9f992bcd

The Feasibility of Developing a Universal SARS-CoV-2 Vaccine — Europe PMC PMID:41893795

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41893795
DOI: 10.3390/vaccines14030259
License (as archived): solo-consultazione
Archived: 2026-11-04T10:09:10.888Z
SHA-256 of the archived text: f553c25bd81024db4d4734bfe9b821be4bd3941033cb873dfe40c945542a469f
Stable URL of this page: https://metraipolis.com/documento/dc_552a9f992bcd

How to cite

The Feasibility of Developing a Universal SARS-CoV-2 Vaccine — Europe PMC PMID:41893795 — Europe PMC (en), https://europepmc.org/article/MED/41893795 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_552a9f992bcd (Metraipolis archive dc_552a9f992bcd, sha256 f553c25bd81024db4d4734bfe9b821be4bd3941033cb873dfe40c945542a469f)

BibTeX

@misc{dc552a9f992bcd,
  title = {The Feasibility of Developing a Universal SARS-CoV-2 Vaccine — Europe PMC PMID:41893795},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41893795},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_552a9f992bcd; sha256 f553c25bd81024db4d4734bfe9b821be4bd3941033cb873dfe40c945542a469f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41893795. Agents can read the archived copy with the MCP tool read_document.